Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on equity-31%+5.9pp-36.9%+5.2pp-42.1%+21.1pp-63.2%-6.9pp-56.3%+25.9pp
Return on assets-30.1%+5.5pp-35.6%+3.8pp-39.5%+18.8pp-58.3%-4.6pp-53.7%+24.0pp
Liquidity
Current ratio44.3×+0.6×43.8×+18.3×25.5×+10.4×15.1×-11.4×26.5×+12.5×
Quick ratio44.3×+0.6×43.8×+18.3×25.5×+10.4×15.1×-11.4×26.5×+12.5×
Cash ratio0.1×0.0×0.1×0.0×0.1×0.0×-0.1×0.1×+0.1×
Leverage
Interest coverage-8.7×+2.0×-10.7×+3.8×-14.5×+2.0×-16.5×-1.0×-15.5×-2.3×
Per Share
Book value per share$7.70-19.4%$9.56+17.1%$8.17+70.4%$4.79-25.4%$6.42+63.1%
Valuation
Market capitalization$2.23B-22.3%$2.87B-2.4%$2.94B+219%$921.58M-7.6%$997.24M+62.8%
Price / book3.5×-0.9×4.4×-0.7×5.1×+2.2×2.9×0.0×2.9×-0.3×
Earnings yield-6.8%-1.4pp-5.4%+0.4pp-5.8%+14.9pp-20.7%-1.8pp-18.9%+10.1pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Mineralys Therapeutics, Inc.'s ratios come from?
Every ratio is computed from Mineralys Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.